[S02DA03, antipyrine, The metabolism of Antipyrine can be decreased when combined with Clofibrate.]
[G03XB02, ulipristal, The metabolism of Ulipristal can be increased when combined with Clofibrate.]
[L04AA27, fingolimod, The metabolism of Fingolimod can be increased when combined with Clofibrate.]
[J01EC01, sulfamethoxazole, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Clofibrate is combined with Sulfamethoxazole.]
[A10BB04, glibornuride, The risk or severity of hypoglycemia can be increased when Clofibrate is combined with Glibornuride.]
[N06DA01, tacrine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Tacrine is combined with Clofibrate.]
[L02BA01, tamoxifen, The metabolism of Tamoxifen can be increased when combined with Clofibrate.]
[L01CB02, teniposide, The metabolism of Teniposide can be increased when combined with Clofibrate.]
[R03DA04, theophylline, The metabolism of Theophylline can be increased when combined with Clofibrate.]
[L01AC01, thiotepa, The metabolism of Thiotepa can be increased when combined with Clofibrate.]
[A10BB05, tolazamide, The risk or severity of hypoglycemia can be increased when Clofibrate is combined with Tolazamide.]
[V04CA01, tolbutamide, The risk or severity of hypoglycemia can be increased when Clofibrate is combined with Tolbutamide.]
[N02AX02, tramadol, The metabolism of Tramadol can be increased when combined with Clofibrate.]
[L01XF01, tretinoin, The metabolism of Tretinoin can be decreased when combined with Clofibrate.]
[S01BA05, triamcinolone, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Triamcinolone is combined with Clofibrate.]
[N05CD05, triazolam, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Clofibrate is combined with Triazolam.]
[N03AC02, trimethadione, The metabolism of Trimethadione can be increased when combined with Clofibrate.]
[J01EA01, trimethoprim, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Trimethoprim is combined with Clofibrate.]
[J01FA08, troleandomycin, The metabolism of Clofibrate can be decreased when combined with Troleandomycin.]
[R03DX07, roflumilast, The metabolism of Roflumilast can be increased when combined with Clofibrate.]
[L01EX04, vandetanib, The metabolism of Vandetanib can be increased when combined with Clofibrate.]
[A10BH05, linagliptin, The metabolism of Clofibrate can be decreased when combined with Linagliptin.]
[J05AP03, boceprevir, The metabolism of Clofibrate can be decreased when combined with Boceprevir.]
[J05AP02, telaprevir, The metabolism of Clofibrate can be decreased when combined with Telaprevir.]
[J05AG05, rilpivirine, The serum concentration of Rilpivirine can be decreased when it is combined with Clofibrate.]
[C08DA01, verapamil, The metabolism of Clofibrate can be decreased when combined with Verapamil.]
[N06AX09, viloxazine, The metabolism of Clofibrate can be decreased when combined with Viloxazine.]
[L01CA01, vinblastine, The metabolism of Vinblastine can be increased when combined with Clofibrate.]
[L01CA02, vincristine, The metabolism of Vincristine can be increased when combined with Clofibrate.]
[L01CA03, vindesine, The metabolism of Vindesine can be increased when combined with Clofibrate.]
[B01AA03, warfarin, The metabolism of Warfarin can be increased when combined with Clofibrate.]
[J05AF01, zidovudine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Zidovudine is combined with Clofibrate.]
[N05AF05, zuclopenthixol, The metabolism of Zuclopenthixol can be increased when combined with Clofibrate.]
[J05AE02, indinavir, The metabolism of Clofibrate can be decreased when combined with Indinavir.]
[L01EC01, vemurafenib, The metabolism of Vemurafenib can be increased when combined with Clofibrate.]
[M05BA03, pamidronic acid, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Pamidronic acid is combined with Clofibrate.]
[L01FX05, brentuximab vedotin, The metabolism of Brentuximab vedotin can be increased when combined with Clofibrate.]
[L01ED01, crizotinib, The metabolism of Crizotinib can be increased when combined with Clofibrate.]
[M05BA06, ibandronic acid, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Clofibrate is combined with Ibandronate.]
[N05AE04, ziprasidone, The metabolism of Clofibrate can be decreased when combined with Ziprasidone.]
[G03AC10, drospirenone, The metabolism of Drospirenone can be increased when combined with Clofibrate.]
[L01EJ01, ruxolitinib, The metabolism of Ruxolitinib can be increased when combined with Clofibrate.]
[J02AC03, voriconazole, The metabolism of Clofibrate can be decreased when combined with Voriconazole.]
[L01EK01, axitinib, The metabolism of Axitinib can be increased when combined with Clofibrate.]
[G04BE10, avanafil, The serum concentration of Avanafil can be increased when it is combined with Clofibrate.]
[M03BX01, baclofen, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Baclofen is combined with Clofibrate.]
[A08AA11, lorcaserin, The metabolism of Lorcaserin can be decreased when combined with Clofibrate.]
[V03AX03, cobicistat, The metabolism of Clofibrate can be decreased when combined with Cobicistat.]
[J05AJ02, elvitegravir, The metabolism of Clofibrate can be decreased when combined with Elvitegravir.]
[L02BB04, enzalutamide, The serum concentration of Clofibrate can be decreased when it is combined with Enzalutamide.]
[L01EA04, bosutinib, The metabolism of Bosutinib can be increased when combined with Clofibrate.]
[L01EX05, regorafenib, The metabolism of Regorafenib can be increased when combined with Clofibrate.]
[J05AE04, nelfinavir, The metabolism of Clofibrate can be decreased when combined with Nelfinavir.]
[C08CA13, lercanidipine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Lercanidipine is combined with Clofibrate.]
[N03AX22, perampanel, The metabolism of Perampanel can be increased when combined with Clofibrate.]
[G04BE03, sildenafil, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Sildenafil is combined with Clofibrate.]
[L01EA05, ponatinib, The metabolism of Ponatinib can be increased when combined with Clofibrate.]
[C10AX12, lomitapide, The metabolism of Lomitapide can be increased when combined with Clofibrate.]
[L04AX06, pomalidomide, The metabolism of Pomalidomide can be increased when combined with Clofibrate.]
[A10AE05, insulin detemir, The risk or severity of hypoglycemia can be increased when Clofibrate is combined with Insulin detemir.]
[R02AD01, benzocaine, The metabolism of Benzocaine can be increased when combined with Clofibrate.]
[C10AC04, colesevelam, Colesevelam can cause a decrease in the absorption of Clofibrate resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[L04AA18, everolimus, The metabolism of Everolimus can be increased when combined with Clofibrate.]
[L01EC02, dabrafenib, The serum concentration of Clofibrate can be decreased when it is combined with Dabrafenib.]
[P03AX06, benzyl alcohol, The metabolism of Benzyl alcohol can be increased when combined with Clofibrate.]
[N06AX28, levomilnacipran, The metabolism of Levomilnacipran can be increased when combined with Clofibrate.]
[A05AA03, cholic acid, The therapeutic efficacy of Cholic Acid can be decreased when used in combination with Clofibrate.]
[N06AX26, vortioxetine, The metabolism of Vortioxetine can be decreased when combined with Clofibrate.]
[G03AC08, etonogestrel, The metabolism of Etonogestrel can be increased when combined with Clofibrate.]
[J05AP05, simeprevir, The metabolism of Clofibrate can be decreased when combined with Simeprevir.]
[A10BK01, dapagliflozin, The metabolism of Dapagliflozin can be decreased when combined with Clofibrate.]
[N05CH03, tasimelteon, The metabolism of Tasimelteon can be increased when combined with Clofibrate.]
[A16AA07, metreleptin, The metabolism of Clofibrate can be increased when combined with Metreleptin.]
[L04AA32, apremilast, The metabolism of Apremilast can be decreased when combined with Clofibrate.]
[S03BA03, betamethasone, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Betamethasone is combined with Clofibrate.]
[C10AB02, bezafibrate, The risk or severity of adverse effects can be increased when Clofibrate is combined with Bezafibrate.]
[L01ED02, ceritinib, The metabolism of Ceritinib can be increased when combined with Clofibrate.]
[B01AC26, vorapaxar, The metabolism of Vorapaxar can be increased when combined with Clofibrate.]
[B01AA07, acenocoumarol, The metabolism of Acenocoumarol can be increased when combined with Clofibrate.]
[L01EM01, idelalisib, The metabolism of Idelalisib can be increased when combined with Clofibrate.]
[N05CM19, suvorexant, The metabolism of Suvorexant can be increased when combined with Clofibrate.]
[L04AX05, pirfenidone, The metabolism of Pirfenidone can be increased when combined with Clofibrate.]
[L01EX09, nintedanib, The metabolism of Nintedanib can be increased when combined with Clofibrate.]
[L01XK01, olaparib, The metabolism of Olaparib can be increased when combined with Clofibrate.]
[B01AA01, dicumarol, The risk or severity of bleeding can be increased when Clofibrate is combined with Dicoumarol.]
[L01EF01, palbociclib, The metabolism of Palbociclib can be increased when combined with Clofibrate.]
[L01XH03, panobinostat, The metabolism of Panobinostat can be increased when combined with Clofibrate.]
[N02BE01, acetaminophen, Clofibrate may increase the hepatotoxic activities of Acetaminophen.]
[B01AA11, tioclomarol, The risk or severity of bleeding can be increased when Clofibrate is combined with Tioclomarol.]
[J05AP06, asunaprevir, The metabolism of Asunaprevir can be decreased when combined with Clofibrate.]
[L01XJ02, sonidegib, The metabolism of Sonidegib can be increased when combined with Clofibrate.]
[A10AE06, insulin degludec, The risk or severity of hypoglycemia can be increased when Clofibrate is combined with Insulin degludec.]
[C10AD06, acipimox, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Clofibrate is combined with Acipimox.]
[L01CX01, trabectedin, The metabolism of Trabectedin can be increased when combined with Clofibrate.]
[J02AC05, isavuconazole, The metabolism of Clofibrate can be decreased when combined with Isavuconazole.]
[L01EB04, osimertinib, The metabolism of Osimertinib can be increased when combined with Clofibrate.]
[J05AF13, tenofovir alafenamide, The metabolism of Tenofovir alafenamide can be increased when combined with Clofibrate.]
[L01EE02, cobimetinib, The metabolism of Cobimetinib can be increased when combined with Clofibrate.]
[L01XG03, ixazomib, The metabolism of Ixazomib can be increased when combined with Clofibrate.]
[L01ED03, alectinib, The metabolism of Alectinib can be increased when combined with Clofibrate.]
[A10BB31, acetohexamide, The risk or severity of hypoglycemia can be increased when Clofibrate is combined with Acetohexamide.]
[L01XX52, venetoclax, The metabolism of Venetoclax can be increased when combined with Clofibrate.]
[C08CA01, amlodipine, The metabolism of Amlodipine can be increased when combined with Clofibrate.]
[N05AX17, pimavanserin, The metabolism of Pimavanserin can be increased when combined with Clofibrate.]
[A05AA04, obeticholic acid, The therapeutic efficacy of Obeticholic acid can be decreased when used in combination with Clofibrate.]
[C03CA02, bumetanide, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Clofibrate is combined with Bumetanide.]
[L01AB01, busulfan, The metabolism of Busulfan can be increased when combined with Clofibrate.]
[S01GX07, azelastine, The metabolism of Azelastine can be decreased when combined with Clofibrate.]
[S01AA26, azithromycin, The metabolism of Azithromycin can be increased when combined with Clofibrate.]
[L01EF02, ribociclib, The metabolism of Clofibrate can be decreased when combined with Ribociclib.]
[J05AE09, tipranavir, The metabolism of Clofibrate can be decreased when combined with Tipranavir.]
[L04AB02, infliximab, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Infliximab is combined with Clofibrate.]
[L01EX10, midostaurin, The metabolism of Clofibrate can be decreased when combined with Midostaurin.]
[L01ED04, brigatinib, The metabolism of Brigatinib can be increased when combined with Clofibrate.]
[L01XX59, enasidenib, The metabolism of Enasidenib can be increased when combined with Clofibrate.]
[L01EH02, neratinib, The metabolism of Neratinib can be increased when combined with Clofibrate.]
[L01EM02, copanlisib, The metabolism of Copanlisib can be increased when combined with Clofibrate.]
[L01EF03, abemaciclib, The metabolism of Abemaciclib can be increased when combined with Clofibrate.]
[J05AG03, efavirenz, The metabolism of Clofibrate can be decreased when combined with Efavirenz.]
[L01EL02, acalabrutinib, The metabolism of Acalabrutinib can be increased when combined with Clofibrate.]
[C09AA01, captopril, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Clofibrate is combined with Captopril.]
[L02BB05, apalutamide, The metabolism of Clofibrate can be increased when combined with Apalutamide.]
[N03AF01, carbamazepine, The metabolism of Carbamazepine can be increased when combined with Clofibrate.]
[H03BB01, carbimazole, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Carbimazole is combined with Clofibrate.]
[C07AG02, carvedilol, The metabolism of Carvedilol can be increased when combined with Clofibrate.]
[L01XX62, ivosidenib, The metabolism of Clofibrate can be increased when combined with Ivosidenib.]
[N03AX17, stiripentol, The metabolism of Clofibrate can be decreased when combined with Stiripentol.]
[L01EM04, duvelisib, The metabolism of Duvelisib can be increased when combined with Clofibrate.]
[L01EB07, dacomitinib, The metabolism of Dacomitinib can be increased when combined with Clofibrate.]
[A10BB06, carbutamide, The risk or severity of hypoglycemia can be increased when Clofibrate is combined with Carbutamide.]
[L01EX13, gilteritinib, The metabolism of Gilteritinib can be increased when combined with Clofibrate.]
[C10AB08, ciprofibrate, The risk or severity of adverse effects can be increased when Clofibrate is combined with Ciprofibrate.]
[L04AA42, siponimod, The metabolism of Siponimod can be increased when combined with Clofibrate.]
[J01FA09, clarithromycin, The metabolism of Clofibrate can be decreased when combined with Clarithromycin.]
[L01EN01, erdafitinib, The metabolism of Erdafitinib can be increased when combined with Clofibrate.]
[C01EB09, ubidecarenone, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Clofibrate is combined with Ubidecarenone.]
[V03AE02, sevelamer, Sevelamer can cause a decrease in the absorption of Clofibrate resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[L01EM03, alpelisib, The metabolism of Alpelisib can be increased when combined with Clofibrate.]
[L01EX15, pexidartinib, The metabolism of Pexidartinib can be increased when combined with Clofibrate.]
[L01EX14, entrectinib, The metabolism of Entrectinib can be increased when combined with Clofibrate.]
[N07XX11, pitolisant, The serum concentration of Clofibrate can be decreased when it is combined with Pitolisant.]
[J04AK08, pretomanid, The metabolism of Pretomanid can be increased when combined with Clofibrate.]
[J01XX12, lefamulin, The metabolism of Lefamulin can be increased when combined with Clofibrate.]
[A10AE03, insulin, regular, pork, The risk or severity of hypoglycemia can be increased when Clofibrate is combined with Insulin pork.]
[J01XX09, daptomycin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Daptomycin is combined with Clofibrate.]
[J01DB01, cephalexin, The metabolism of Cephalexin can be increased when combined with Clofibrate.]
[G03DB05, demegestone, The metabolism of Demegestone can be increased when combined with Clofibrate.]
[L01FD03, ado-trastuzumab emtansine, The metabolism of Trastuzumab emtansine can be increased when combined with Clofibrate.]
[L01EL03, zanubrutinib, The metabolism of Zanubrutinib can be increased when combined with Clofibrate.]
[G03AC09, desogestrel, The metabolism of Desogestrel can be increased when combined with Clofibrate.]
[N03AX25, cenobamate, The serum concentration of Clofibrate can be decreased when it is combined with Cenobamate.]
[N05CM21, lemborexant, The serum concentration of Lemborexant can be decreased when it is combined with Clofibrate.]
[L01XX72, tazemetostat, The metabolism of Tazemetostat can be increased when combined with Clofibrate.]
[N05AD10, lumateperone, The serum concentration of Lumateperone can be decreased when it is combined with Clofibrate.]
[N02CD06, rimegepant, The metabolism of Rimegepant can be increased when combined with Clofibrate.]
[J05AE05, amprenavir, The metabolism of Clofibrate can be decreased when combined with Amprenavir.]
[L01EE04, selumetinib, The metabolism of Selumetinib can be increased when combined with Clofibrate.]
[G03DB08, dienogest, The metabolism of Dienogest can be increased when combined with Clofibrate.]
[C01BD07, dronedarone, The metabolism of Dronedarone can be increased when combined with Clofibrate.]
[L01EH03, tucatinib, The metabolism of Tucatinib can be decreased when combined with Clofibrate.]
[L01EX17, capmatinib, The serum concentration of Capmatinib can be decreased when it is combined with Clofibrate.]
[L01EX22, selpercatinib, The serum concentration of Selpercatinib can be decreased when it is combined with Clofibrate.]
[N05CM02, chlormethiazole, The metabolism of Clomethiazole can be decreased when combined with Clofibrate.]
[R06AX22, ebastine, The metabolism of Ebastine can be increased when combined with Clofibrate.]
[L04AC19, satralizumab, The serum concentration of Clofibrate can be decreased when it is combined with Satralizumab.]
[N02AX07, oliceridine, The serum concentration of Oliceridine can be decreased when it is combined with Clofibrate.]
[P01BA01, chloroquine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Chloroquine is combined with Clofibrate.]
[N05AA01, chlorpromazine, The metabolism of Chlorpromazine can be increased when combined with Clofibrate.]
[A10BB02, chlorpropamide, The risk or severity of hypoglycemia can be increased when Clofibrate is combined with Chlorpropamide.]
[M03BB03, chlorzoxazone, The metabolism of Chlorzoxazone can be increased when combined with Clofibrate.]
[C10AC01, cholestyramine resin, Cholestyramine can cause a decrease in the absorption of Clofibrate resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[G03DC06, ethynodiol, The metabolism of Etynodiol can be increased when combined with Clofibrate.]
[M02AA06, etofenamate, The therapeutic efficacy of Etofenamate can be decreased when used in combination with Clofibrate.]
[C10AB09, etofibrate, The risk or severity of adverse effects can be increased when Clofibrate is combined with Etofibrate.]
[B06AC06, berotralstat, The metabolism of Clofibrate can be decreased when combined with Berotralstat.]
[A16AX20, lonafarnib, The metabolism of Clofibrate can be decreased when combined with Lonafarnib.]
[P03AX07, abametapir, The serum concentration of Clofibrate can be increased when it is combined with Abametapir.]
[N03AX10, felbamate, The metabolism of Felbamate can be increased when combined with Clofibrate.]
[R03CC15, formoterol, The metabolism of Formoterol can be decreased when combined with Clofibrate.]
[A10AF01, insulin, regular, human, The risk or severity of hypoglycemia can be increased when Clofibrate is combined with Insulin human.]
[L01EK03, tivozanib, The metabolism of Tivozanib can be increased when combined with Clofibrate.]
[A02BA01, cimetidine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Cimetidine is combined with Clofibrate.]
[N07CA02, cinnarizine, The metabolism of Cinnarizine can be decreased when combined with Clofibrate.]
[L01XX73, sotorasib, The serum concentration of Clofibrate can be decreased when it is combined with Sotorasib.]
[L01EN03, infigratinib, The metabolism of Infigratinib can be increased when combined with Clofibrate.]
[S03AA07, ciprofloxacin, The metabolism of Clofibrate can be decreased when combined with Ciprofloxacin.]
[A10BB12, glimepiride, The risk or severity of hypoglycemia can be increased when Clofibrate is combined with Glimepiride.]
[A10BB08, gliquidone, The risk or severity of hypoglycemia can be increased when Clofibrate is combined with Gliquidone.]
[J01FF01, clindamycin, The metabolism of Clindamycin can be increased when combined with Clofibrate.]
[N06AX25, St. John's wort extract, The metabolism of Clofibrate can be increased when combined with St. John's Wort.]
[S01AA13, fusidic acid, The metabolism of Clofibrate can be decreased when combined with Fusidic acid.]
[N06AA04, clomipramine, The metabolism of Clomipramine can be increased when combined with Clofibrate.]
[N03AE01, clonazepam, The metabolism of Clonazepam can be increased when combined with Clofibrate.]
[S01EA04, clonidine, The metabolism of Clonidine can be increased when combined with Clofibrate.]
[C01EB24, mavacamten, The serum concentration of Clofibrate can be decreased when it is combined with Mavacamten.]
[N05AH02, clozapine, The metabolism of Clofibrate can be decreased when combined with Clozapine.]
[H01AC08, somatrogon, The metabolism of Clofibrate can be increased when combined with Somatrogon.]
[M04AC01, colchicine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Clofibrate is combined with Colchicine.]
[C10AC02, colestipol, Colestipol can cause a decrease in the absorption of Clofibrate resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[L04AA13, leflunomide, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Clofibrate is combined with Leflunomide.]
[A10AE04, insulin glargine, The risk or severity of hypoglycemia can be increased when Clofibrate is combined with Insulin glargine.]
[J01FA15, telithromycin, The metabolism of Clofibrate can be decreased when combined with Telithromycin.]
[J02AC02, itraconazole, The metabolism of Clofibrate can be decreased when combined with Itraconazole.]
[J02AC04, posaconazole, The metabolism of Clofibrate can be decreased when combined with Posaconazole.]
[H01CA02, nafarelin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Clofibrate is combined with Nafarelin.]
[A03AA04, mebeverine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Clofibrate is combined with Mebeverine.]
[L01AA01, cyclophosphamide, The metabolism of Cyclophosphamide can be increased when combined with Clofibrate.]
[S01XA18, cyclosporine, The risk or severity of renal failure can be increased when Cyclosporine is combined with Clofibrate.]
[C10AA07, rosuvastatin, The risk or severity of myopathy and rhabdomyolysis can be increased when Clofibrate is combined with Rosuvastatin.]
[C03XA02, conivaptan, The metabolism of Clofibrate can be decreased when combined with Conivaptan.]
[L01BC01, cytarabine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Clofibrate is combined with Cytarabine.]
[G03XA01, danazol, The metabolism of Clofibrate can be decreased when combined with Danazol.]
[M03CA01, dantrolene, The therapeutic efficacy of Dantrolene can be decreased when used in combination with Clofibrate.]
[N06AX06, nefazodone, The metabolism of Clofibrate can be decreased when combined with Nefazodone.]
[G03DB04, nomegestrol, The metabolism of Nomegestrol can be increased when combined with Clofibrate.]
[S03BA01, dexamethasone, The metabolism of Clofibrate can be increased when combined with Dexamethasone.]
[L01DC04, ixabepilone, The metabolism of Ixabepilone can be increased when combined with Clofibrate.]
[L01EB02, erlotinib, The serum concentration of Erlotinib can be decreased when it is combined with Clofibrate.]
[L02AA01, diethylstilbestrol, The metabolism of Diethylstilbestrol can be increased when combined with Clofibrate.]
[C08CA03, isradipine, The metabolism of Clofibrate can be decreased when combined with Isradipine.]
[C01AA04, digitoxin, The metabolism of Digitoxin can be increased when combined with Clofibrate.]
[C10AX09, ezetimibe, The serum concentration of Ezetimibe can be increased when it is combined with Clofibrate.]
[C04AE04, dihydroergocristine, The metabolism of Dihydroergocristine can be increased when combined with Clofibrate.]
[N02CA01, dihydroergotamine, The metabolism of Dihydroergotamine can be increased when combined with Clofibrate.]
[J05AE08, atazanavir, The metabolism of Clofibrate can be decreased when combined with Atazanavir.]
[C08DB01, diltiazem, The metabolism of Clofibrate can be decreased when combined with Diltiazem.]
[A03FA02, cisapride, The metabolism of Cisapride can be increased when combined with Clofibrate.]
[S01XA23, sirolimus, The metabolism of Sirolimus can be increased when combined with Clofibrate.]
[S02AA12, rifamycin SV, The metabolism of Clofibrate can be increased when combined with Rifamycin.]
[J04AB05, rifapentine, The metabolism of Clofibrate can be increased when combined with Rifapentine.]
[L01EX01, sunitinib, The metabolism of Sunitinib can be increased when combined with Clofibrate.]
[A04AD12, aprepitant, The metabolism of Clofibrate can be decreased when combined with Aprepitant.]
[C03XA01, tolvaptan, The metabolism of Tolvaptan can be increased when combined with Clofibrate.]
[L01XG01, bortezomib, The metabolism of Bortezomib can be increased when combined with Clofibrate.]
[C01EB18, ranolazine, The metabolism of Ranolazine can be increased when combined with Clofibrate.]
[R03AC12, salmeterol, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Clofibrate is combined with Salmeterol.]
[L01DB01, doxorubicin, The metabolism of Doxorubicin can be increased when combined with Clofibrate.]
[N01AB08, sevoflurane, The metabolism of Sevoflurane can be increased when combined with Clofibrate.]
[C10AA01, simvastatin, The risk or severity of myopathy and rhabdomyolysis can be increased when Clofibrate is combined with Simvastatin.]
[D01BA02, terbinafine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Clofibrate is combined with Terbinafine.]
[P01AX02, emetine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Clofibrate is combined with Emetine.]
[N06AX14, tianeptine, The metabolism of Tianeptine can be increased when combined with Clofibrate.]
[C09AA02, enalapril, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Enalapril is combined with Clofibrate.]
[N01AB04, enflurane, The metabolism of Enflurane can be increased when combined with Clofibrate.]
[L01CA04, vinorelbine, The metabolism of Vinorelbine can be increased when combined with Clofibrate.]
[C08CA12, mepirodipine, The metabolism of Clofibrate can be decreased when combined with Barnidipine.]
[N05CF02, zolpidem, The metabolism of Zolpidem can be increased when combined with Clofibrate.]
[A10AB06, insulin glulisine, human, The risk or severity of hypoglycemia can be increased when Clofibrate is combined with Insulin glulisine.]
[B01AC11, iloprost, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Clofibrate is combined with Iloprost.]
[N02CA02, ergotamine, The metabolism of Clofibrate can be decreased when combined with Ergotamine.]
[S01AA17, erythromycin, The metabolism of Clofibrate can be decreased when combined with Erythromycin.]
[G03CA03, estradiol, The metabolism of Estradiol can be increased when combined with Clofibrate.]
[C10AA04, fluvastatin, The risk or severity of myopathy and rhabdomyolysis can be increased when Clofibrate is combined with Fluvastatin.]
[L02AA03, ethinyl estradiol, The serum concentration of Clofibrate can be decreased when it is combined with Ethinylestradiol.]
[N03AD01, ethosuximide, The metabolism of Ethosuximide can be increased when combined with Clofibrate.]
[N03AB01, ethotoin, The therapeutic efficacy of Ethotoin can be decreased when used in combination with Clofibrate.]
[L01CB01, etoposide, The metabolism of Etoposide can be increased when combined with Clofibrate.]
[L04AD02, tacrolimus, Tacrolimus may increase the nephrotoxic activities of Clofibrate.]
[A02BA04, nizatidine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Nizatidine is combined with Clofibrate.]
[R06AX11, astemizole, The metabolism of Astemizole can be increased when combined with Clofibrate.]
[R06AX12, terfenadine, The metabolism of Clofibrate can be decreased when combined with Terfenadine.]
[N06AB08, fluvoxamine, The metabolism of Clofibrate can be decreased when combined with Fluvoxamine.]
[L02AE02, leuprolide, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Clofibrate.]
[C10AA03, pravastatin, The risk or severity of myopathy and rhabdomyolysis can be increased when Clofibrate is combined with Pravastatin.]
[D11AX24, deoxycholic acid, The therapeutic efficacy of Deoxycholic acid can be decreased when used in combination with Clofibrate.]
[P02CA03, albendazole, The metabolism of Albendazole can be increased when combined with Clofibrate.]
[L04AA40, cladribine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Cladribine is combined with Clofibrate.]
[J02AC01, fluconazole, The metabolism of Clofibrate can be decreased when combined with Fluconazole.]
[N07CA03, flunarizine, The metabolism of Flunarizine can be decreased when combined with Clofibrate.]
[N05CD03, flunitrazepam, The metabolism of Flunitrazepam can be decreased when combined with Clofibrate.]
[V03AZ01, ethanol, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Clofibrate is combined with Ethanol.]
[L01BC02, fluorouracil, The metabolism of Fluorouracil can be decreased when combined with Clofibrate.]
[N05CD01, flurazepam, The metabolism of Flurazepam can be decreased when combined with Clofibrate.]
[L01BC03, tegafur, The metabolism of Tegafur can be decreased when combined with Clofibrate.]
[J05AE10, darunavir, The metabolism of Clofibrate can be decreased when combined with Darunavir.]
[C03CA01, furosemide, The therapeutic efficacy of Furosemide can be decreased when used in combination with Clofibrate.]
[N05CF04, eszopiclone, The serum concentration of Eszopiclone can be decreased when it is combined with Clofibrate.]
[S01AD09, ganciclovir, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Clofibrate is combined with Ganciclovir.]
[C10AB04, gemfibrozil, The risk or severity of adverse effects can be increased when Clofibrate is combined with Gemfibrozil.]
[L01EA02, dasatinib, The metabolism of Dasatinib can be increased when combined with Clofibrate.]
[N04BC06, cabergoline, The metabolism of Cabergoline can be increased when combined with Clofibrate.]
[G03XA02, gestrinone, The metabolism of Gestrinone can be increased when combined with Clofibrate.]
[A10BB01, glyburide, The risk or severity of hypoglycemia can be increased when Clofibrate is combined with Glyburide.]
[A10BB09, gliclazide, The risk or severity of hypoglycemia can be increased when Clofibrate is combined with Gliclazide.]
[A10BB07, glipizide, The risk or severity of hypoglycemia can be increased when Clofibrate is combined with Glipizide.]
[C01BD04, dofetilide, The metabolism of Dofetilide can be increased when combined with Clofibrate.]
[C02CA04, doxazosin, The metabolism of Doxazosin can be increased when combined with Clofibrate.]
[L01EX02, sorafenib, The metabolism of Sorafenib can be increased when combined with Clofibrate.]
[B01AA12, fluindione, The risk or severity of bleeding can be increased when Clofibrate is combined with Fluindione.]
[N05AD01, haloperidol, The serum concentration of Haloperidol can be increased when it is combined with Clofibrate.]
[N01AB01, halothane, The metabolism of Halothane can be increased when combined with Clofibrate.]
[A10AD05, insulin aspart, human, The risk or severity of hypoglycemia can be increased when Clofibrate is combined with Insulin aspart.]
[L01CE02, irinotecan, The metabolism of Irinotecan can be increased when combined with Clofibrate.]
[S01XA14, heparin, The therapeutic efficacy of Heparin can be decreased when used in combination with Clofibrate.]
[G03DC01, allylestrenol, The metabolism of Allylestrenol can be increased when combined with Clofibrate.]
[J05AG01, nevirapine, The metabolism of Nevirapine can be decreased when combined with Clofibrate.]
[C08CA10, nilvadipine, The metabolism of Clofibrate can be decreased when combined with Nilvadipine.]
[M05BA07, risedronic acid, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Clofibrate is combined with Risedronic acid.]
[L01AA06, ifosfamide, The metabolism of Ifosfamide can be increased when combined with Clofibrate.]
[L01CD01, paclitaxel, The metabolism of Paclitaxel can be increased when combined with Clofibrate.]
[N06AX17, milnacipran, The metabolism of Milnacipran can be increased when combined with Clofibrate.]
[C10AA06, cerivastatin, The risk or severity of myopathy and rhabdomyolysis can be increased when Clofibrate is combined with Cerivastatin.]
[V03AB01, ipecac, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Clofibrate is combined with Ipecac.]
[J05AF04, stavudine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Clofibrate is combined with Stavudine.]
[N01AB06, isoflurane, The metabolism of Isoflurane can be increased when combined with Clofibrate.]
[J04AC01, isoniazid, The metabolism of Clofibrate can be decreased when combined with Isoniazid.]
[D10BA01, isotretinoin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Clofibrate is combined with Isotretinoin.]
[P02CF01, ivermectin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ivermectin is combined with Clofibrate.]
[H01AC01, somatropin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Clofibrate.]
[J02AB02, ketoconazole, The metabolism of Clofibrate can be decreased when combined with Ketoconazole.]
[N03AX18, lacosamide, The metabolism of Lacosamide can be increased when combined with Clofibrate.]
[G03AD01, levonorgestrel, The metabolism of Levonorgestrel can be increased when combined with Clofibrate.]
[D06AX13, retapamulin, The metabolism of Retapamulin can be increased when combined with Clofibrate.]
[C10AA02, lovastatin, The metabolism of Clofibrate can be decreased when combined with Lovastatin.]
[G03DC03, lynestrenol, The metabolism of Lynestrenol can be increased when combined with Clofibrate.]
[L01EG01, temsirolimus, The metabolism of Temsirolimus can be increased when combined with Clofibrate.]
[L01EA03, nilotinib, The metabolism of Clofibrate can be decreased when combined with Nilotinib.]
[M02AA18, meclofenamic acid, The therapeutic efficacy of Meclofenamic acid can be decreased when used in combination with Clofibrate.]
[P01BC02, mefloquine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Mefloquine is combined with Clofibrate.]
[N02AB02, meperidine, The metabolism of Meperidine can be increased when combined with Clofibrate.]
[N03AB04, mephenytoin, The therapeutic efficacy of Mephenytoin can be decreased when used in combination with Clofibrate.]
[J05AF05, lamivudine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Clofibrate is combined with Lamivudine.]
[H03BB02, methimazole, The metabolism of Clofibrate can be decreased when combined with Methimazole.]
[L04AX03, methotrexate, The metabolism of Methotrexate can be increased when combined with Clofibrate.]
[N02BG09, methoxyflurane, The metabolism of Methoxyflurane can be increased when combined with Clofibrate.]
[C02AB01, methyldopa, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Clofibrate is combined with Methyldopa.]
[R03DA05, aminophylline, The metabolism of Aminophylline can be increased when combined with Clofibrate.]
[N02CA04, methysergide, The metabolism of Methysergide can be increased when combined with Clofibrate.]
[A03FA01, metoclopramide, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Clofibrate is combined with Metoclopramide.]
[P01AB01, metronidazole, The metabolism of Metronidazole can be decreased when combined with Clofibrate.]
[S02AA13, miconazole, The metabolism of Clofibrate can be decreased when combined with Miconazole.]
[G03XB01, mifepristone, The metabolism of Mifepristone can be increased when combined with Clofibrate.]
[J01AA08, minocycline, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Clofibrate is combined with Minocycline.]
[L01XX23, mitotane, The metabolism of Clofibrate can be increased when combined with Mitotane.]
[C01BD01, amiodarone, The metabolism of Clofibrate can be decreased when combined with Amiodarone.]
[L01EX03, pazopanib, The metabolism of Pazopanib can be increased when combined with Clofibrate.]
[J05AJ01, raltegravir, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Clofibrate is combined with Raltegravir.]
[N03AB05, fosphenytoin, The metabolism of Fosphenytoin can be increased when combined with Clofibrate.]
[V03AB15, naloxone, The metabolism of Clofibrate can be decreased when combined with Naloxone.]
[N07BB04, naltrexone, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Clofibrate is combined with Naltrexone.]
[L01CD02, docetaxel, The metabolism of Docetaxel can be increased when combined with Clofibrate.]
[L02BG04, letrozole, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Clofibrate is combined with Letrozole.]
[J02AA01, amphotericin B, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Clofibrate is combined with Amphotericin B.]
[N06AX23, desvenlafaxine, The metabolism of Clofibrate can be decreased when combined with Desvenlafaxine.]
[C10AD02, niacin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Niacin is combined with Clofibrate.]
[C08CA04, nicardipine, The metabolism of Clofibrate can be decreased when combined with Nicardipine.]
[N07BA01, nicotine, The metabolism of Nicotine can be decreased when combined with Clofibrate.]
[C08CA05, nifedipine, The metabolism of Nifedipine can be decreased when combined with Clofibrate.]
[J01XE01, nitrofurantoin, The therapeutic efficacy of Nitrofurantoin can be decreased when used in combination with Clofibrate.]
[G03DC02, norethindrone, The metabolism of Norethisterone can be increased when combined with Clofibrate.]
[S01AE02, norfloxacin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Clofibrate is combined with Norfloxacin.]
[G03AC07, norgestrienone, The metabolism of Norgestrienone can be increased when combined with Clofibrate.]
[N06AA10, nortriptyline, The metabolism of Nortriptyline can be increased when combined with Clofibrate.]
[S02AA16, ofloxacin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Clofibrate is combined with Ofloxacin.]
[G03DB06, chlormadinone, The metabolism of Chlormadinone can be increased when combined with Clofibrate.]
[M01CC01, penicillamine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Clofibrate is combined with Penicillamine.]
[N05CA01, pentobarbital, The metabolism of Clofibrate can be increased when combined with Pentobarbital.]
[N02BE03, phenacetin, The metabolism of Phenacetin can be decreased when combined with Clofibrate.]
[B01AA02, phenindione, The risk or severity of bleeding can be increased when Clofibrate is combined with Phenindione.]
[N03AA02, phenobarbital, The metabolism of Phenobarbital can be increased when combined with Clofibrate.]
[B01AA04, phenprocoumon, The metabolism of Phenprocoumon can be increased when combined with Clofibrate.]
[N03AB02, phenytoin, The metabolism of Clofibrate can be increased when combined with Phenytoin.]
[L02BB03, bicalutamide, The metabolism of Bicalutamide can be increased when combined with Clofibrate.]
[N05AG02, pimozide, The metabolism of Pimozide can be increased when combined with Clofibrate.]
[C10AA05, atorvastatin, The risk or severity of myopathy and rhabdomyolysis can be increased when Clofibrate is combined with Atorvastatin.]
[J05AE01, saquinavir, The metabolism of Clofibrate can be decreased when combined with Saquinavir.]
[C09CA02, eprosartan, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Clofibrate is combined with Eprosartan.]
[J05AG02, delavirdine, The metabolism of Clofibrate can be decreased when combined with Delavirdine.]
[A10BG02, rosiglitazone, The metabolism of Rosiglitazone can be increased when combined with Clofibrate.]
[J05AE03, ritonavir, The serum concentration of Clofibrate can be increased when it is combined with Ritonavir.]
[A10AD04, insulin lispro, The risk or severity of hypoglycemia can be increased when Clofibrate is combined with Insulin lispro.]
[C10AA08, pitavastatin, The risk or severity of myopathy and rhabdomyolysis can be increased when Clofibrate is combined with Pitavastatin.]
[P01BA03, primaquine, The metabolism of Clofibrate can be decreased when combined with Primaquine.]
[N03AA03, primidone, The metabolism of Clofibrate can be increased when combined with Primidone.]
[C01BA02, procainamide, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Clofibrate is combined with Procainamide.]
[L01XB01, procarbazine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Clofibrate is combined with Procarbazine.]
[C10AB05, fenofibrate, The risk or severity of adverse effects can be increased when Clofibrate is combined with Fenofibrate.]
[G03DA04, progesterone, The metabolism of Progesterone can be increased when combined with Clofibrate.]
[L01XH02, romidepsin, The metabolism of Romidepsin can be increased when combined with Clofibrate.]
[N01AX10, propofol, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Clofibrate is combined with Propofol.]
[H03BA02, propylthiouracil, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Propylthiouracil is combined with Clofibrate.]
[R03DC03, montelukast, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Montelukast is combined with Clofibrate.]
[N05AX12, aripiprazole, The metabolism of Aripiprazole can be increased when combined with Clofibrate.]
[C01BA01, quinidine, The metabolism of Quinidine can be increased when combined with Clofibrate.]
[A02BA02, ranitidine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Clofibrate is combined with Ranitidine.]
[J04AB02, rifampin, The metabolism of Clofibrate can be increased when combined with Rifampicin.]
[N04BD01, selegiline, The metabolism of Selegiline can be decreased when combined with Clofibrate.]
[L01CD04, cabazitaxel, The metabolism of Cabazitaxel can be increased when combined with Clofibrate.]
[N03AG01, valproic acid, The metabolism of Valproic acid can be decreased when combined with Clofibrate.]
[A05AA01, chenodeoxycholic acid, The therapeutic efficacy of Chenodeoxycholic acid can be decreased when used in combination with Clofibrate.]
[M05BA04, alendronic acid, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Alendronic acid is combined with Clofibrate.]
[H02CA04, levoketoconazole, The metabolism of Clofibrate can be decreased when combined with Levoketoconazole.]
[A05AA02, ursodiol, The therapeutic efficacy of Ursodeoxycholic acid can be decreased when used in combination with Clofibrate.]
